BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16568663)

  • 1. [Effect of Herba Epimedii Flavone on expression of OPG and RANKL in rat osteoblasts].
    Liu Y; Zang H; Zhang H; Chen J
    Zhong Yao Cai; 2005 Dec; 28(12):1076-8. PubMed ID: 16568663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Herba Epimedii flavone on the osteoblasts metabolism in vitro].
    Liu YH; Zhang HY; Zang HM; Cheng JC
    Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(6):487-90. PubMed ID: 16722381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts].
    Tian QX; Huang GY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):418-22. PubMed ID: 15379268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL.
    Bord S; Frith E; Ireland DC; Scott MA; Craig JI; Compston JE
    Bone; 2005 May; 36(5):812-9. PubMed ID: 15794927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.
    Cao J; Venton L; Sakata T; Halloran BP
    J Bone Miner Res; 2003 Feb; 18(2):270-7. PubMed ID: 12568404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
    Humphrey EL; Williams JH; Davie MW; Marshall MJ
    Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The molecule mechanism of soybean isoflavaones antagonizing bone loss induced by postmenopausal osteoporosis].
    Wang Q; Wang K; Wang X
    Zhong Yao Cai; 2005 Oct; 28(10):910-3. PubMed ID: 16479929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin effect on RANKL and OPG expression in MC3T3-E1 osteoblasts.
    Lamghari M; Tavares L; Camboa N; Barbosa MA
    J Cell Biochem; 2006 Aug; 98(5):1123-9. PubMed ID: 16479591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA.
    Baumann B; Rader CP; Seufert J; Nöth U; Rolf O; Eulert J; Jakob F
    Acta Orthop Scand; 2004 Jun; 75(3):295-302. PubMed ID: 15260421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin (OPG) and RANKL expression and distribution in developing human craniomandibular joint.
    Carda C; Silvestrini G; Gomez de Ferraris ME; Peydró A; Bonucci E
    Tissue Cell; 2005 Jun; 37(3):247-55. PubMed ID: 15899507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
    Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck.
    Tsangari H; Findlay DM; Kuliwaba JS; Atkins GJ; Fazzalari NL
    Bone; 2004 Jul; 35(1):334-42. PubMed ID: 15207775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen.
    Bord S; Frith E; Ireland DC; Scott MA; Craig JI; Compston JE
    Br J Haematol; 2004 Jul; 126(2):244-51. PubMed ID: 15238146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
    Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
    J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
    Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
    Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical stimulation effects on functional end effectors in osteoblastic MG-63 cells.
    Saunders MM; Taylor AF; Du C; Zhou Z; Pellegrini VD; Donahue HJ
    J Biomech; 2006; 39(8):1419-27. PubMed ID: 15953606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin is expressed in colon carcinoma cells.
    Pettersen I; Bakkelund W; Smedsrød B; Sveinbjørnsson B
    Anticancer Res; 2005; 25(6B):3809-16. PubMed ID: 16309167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
    Tanabe N; Maeno M; Suzuki N; Fujisaki K; Tanaka H; Ogiso B; Ito K
    Life Sci; 2005 Jun; 77(6):615-26. PubMed ID: 15921993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts.
    Mehrotra M; Saegusa M; Wadhwa S; Voznesensky O; Peterson D; Pilbeam C
    J Cell Biochem; 2006 Aug; 98(5):1271-83. PubMed ID: 16514640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
    Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
    J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.